Healthcare · Healthcare Services
QVM read Quality in motion Quality Strong, Valuation Expensive, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #7 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 1 May 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Buy | 0 | ₹0 |
| 31 Mar 2026 | Rahul Sharma | Director | Sell | 0 | ₹0 |
| 24 Feb 2026 | Abhishek Aggarwal | Employee / designated person | Buy | 0 | ₹0 |
| 24 Feb 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | 0 | ₹0 |
| 19 Feb 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | 0 | ₹0 |
| 11 Feb 2026 | Jitender Sharma | Employee / designated person | Pledge | 0 | ₹35.69 L |
| 4 Feb 2026 | Rahul Sharma | Director | Buy | 0 | ₹0 |
| 31 Dec 2025 | Sanjay Kulshreshtha | Employee / designated person | Buy | 0 | ₹0 |
| 31 Dec 2025 | Sanjay Kulshreshtha | Employee / designated person | Buy | 0 | ₹0 |
| 31 Dec 2025 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 20 Oct 2025 | GOLDMAN SACHS BANK EUROPE SE - ODI | Block | Buy | 33,414 | 3160.0000 | NSE |
| 20 Oct 2025 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | Block | Sell | 33,414 | 3160.0000 | NSE |
| 6 Jan 2025 | MULTI-MANAGER ICVC | Bulk | Sell | 434,943 | 2997.1100 | NSE |
| 25 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | Block | Buy | 12,949 | 2550.9000 | BSE |
| 25 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | Block | Sell | 12,949 | 2550.9000 | BSE |
| 25 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Buy | 69,319 | 2550.9000 | BSE |
| 25 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 69,319 | 2550.9000 | BSE |
| 17 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | Block | Sell | 12,934 | 2377.5000 | BSE |
| 17 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | Block | Buy | 12,934 | 2377.5000 | BSE |
| 17 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 69,250 | 2377.5000 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 30 Jul 2026 | Interim Dividend - Rs 5 Per Share | 5.0000 | 30 Jul 2026 |
| 25 Jun 2026 | Dividend - Rs 4 Per Share | 4.0000 | 26 Jun 2026 |
| 5 Feb 2026 | Interim Dividend - Rs 3.50 Per Share | 3.5000 | 5 Feb 2026 |
| 7 Nov 2025 | Interim Dividend - Rs 7 Per Share | 7.0000 | 7 Nov 2025 |
| 6 Aug 2025 | Interim Dividend - Rs 6 Per Share | 6.0000 | 6 Aug 2025 |
| 6 Jun 2025 | Dividend - Rs 6 Per Share | 6.0000 | 6 Jun 2025 |
| 5 Feb 2025 | Interim Dividend - Rs 6 Per Share | 6.0000 | 5 Feb 2025 |
| 5 Nov 2024 | Interim Dividend - Rs 6 Per Share | 6.0000 | 5 Nov 2024 |
| 20 Aug 2024 | Interim Dividend - Rs 6 Per Share | 6.0000 | 20 Aug 2024 |
| 10 Jun 2024 | Dividend - Rs 6 Per Share | 6.0000 | 10 Jun 2024 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 19 Dec 2025 | BONUS | Bonus 1:1 |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 24 Jul 2026 | Dividend | — |
| 24 Jul 2026 | Financial Results/Other business matters | Yes |
| 30 Apr 2026 | Dividend | — |
| 30 Apr 2026 | Financial Results/Other business matters | Yes |
| 30 Jan 2026 | Dividend | — |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
